UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase II study of cetuximab rechallenge in patients with ras wild-type metastatic colorectal cancer: E-rechallenge trial

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii161

2018

Volltextzugriff (PDF)

A multicenter retrospective study of gemcitabine plus nab-paclitaxel or FOLFIRINOX in metastatic pancreatic cancer: NAPOLEON study

Annals of oncology, 2019-07, Vol.30, p.iv17-iv18

2019

Volltextzugriff (PDF)

Initial report of a phase I/II study of S-1 and irinotecan (IRIS) in combination with cetuximab in patients with wild-type RAS metastatic colorectal cancer

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii166

2018

Volltextzugriff (PDF)

192P A multicenter crossover analysis of first and second-line FOLFIRINOX or gemcitabine plus nab-paclitaxel administered to pancreatic cancer patients: Results from the NAPOLEON study

Annals of oncology, 2020-11, Vol.31, p.S1314-S1314

2020

Volltextzugriff (PDF)

SO-1 Prognostic nomogram to predict overall survival in patients with unresectable pancreatic cancer treated with gemcitabine plus nab-paclitaxel or FOLFIRINOX: Real-world results from the multicenter retrospective study (NAPOLEON study)

Annals of oncology, 2020-07, Vol.31, p.S217

2020

Volltextzugriff (PDF)

PD-5 Impact of biliary drainage for unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel: Results from the NAPOLEON study

Annals of oncology, 2020-07, Vol.31, p.S213

2020

Volltextzugriff (PDF)

P-88 A multicenter analysis of the correlation between overall survival and progression-free survival and the number of chemotherapeutic key drugs used in patients with advanced/unresectable pancreatic cancer: Results from the NAPOLEON study

Annals of oncology, 2020-07, Vol.31, p.S118

2020

Volltextzugriff (PDF)

Oxaliplatin-Induced Hypersensitivity Reactions in Patients with Advanced Colorectal Cancer in a Single Hospital

Annals of oncology, 2012-10, Vol.23, p.xi151

2012

Volltextzugriff (PDF)

Development of a novel, fully-automated genotyping system: principle and applications

Sensors, 2012-12, Vol.12 (12), p.16614-16627

2012

Volltextzugriff (PDF)

Prognostic impact of the C-reactive protein/albumin ratio in advanced pancreatic cancer treated with GEM plus nab-PTX or FOLFIRINOX: Based on the results of a multicenter retrospective study (the NAPOLEON study)

Annals of oncology, 2019-11, Vol.30, p.ix58

2019

Volltextzugriff (PDF)

P-065A multicenter retrospective study of gemcitabine plus nab-paclitaxel or FOLFIRINOX in metastatic pancreatic cancer: NAPOLEON study

Annals of oncology, 2019-07, Vol.30 (Supplement_4)

2019

Volltextzugriff (PDF)

481PPhase II study of cetuximab rechallenge in patients with ras wild-type metastatic colorectal cancer: E-rechallenge trial

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

493PInitial report of a phase I/II study of S-1 and irinotecan (IRIS) in combination with cetuximab in patients with wild-type RAS metastatic colorectal cancer

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Gemcitabine Plus Radiotherapy in Patients with Unresectable Locally Advanced Pancreatic Cancer

Annals of oncology, 2012-10, Vol.23, p.xi161

2012

Volltextzugriff (PDF)

A noninvasive system for monitoring resistance to EGFR tyrosine kinase inhibitors with plasma DNA

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e13561-e13561

2011

Volltextzugriff (PDF)

Rectal MALT lymphoma regression and anti-Helicobacter pylori therapy

QJM : An International Journal of Medicine, 2018-10, Vol.111 (10), p.737-738

2018

Volltextzugriff (PDF)

P1301: BIOLOGICAL SIGNIFICANCE OF UCK2 IN HTLV‐1‐INFECTED CELLS IN ATL LEUKEMOGENESIS AND ACQUIRED RESISTANCE TO AZACITIDINE

HemaSphere, 2022-06, Vol.6 (Suppl), p.1186-1187

2022

Volltextzugriff (PDF)

P413: THE POTENTIAL USE OF AN ORAL HYPOMETHYLATING AGENT, OR‐2100, AS A COMBINATION THERAPY FOR MYELOID MALIGNANCIES

HemaSphere, 2022-06, Vol.6, p.313-314

2022

Volltextzugriff (PDF)

ACE2 OVEREXPRESSION CHANGES THE SARS-COV-2 INFECTION PROFILE IN BEAS-2B CELLS

Cytotherapy (Oxford, England), 2021-04, Vol.23 (4), p.1-1

2021

Volltextzugriff (PDF)

Changes in nitrogen uptake with aging and under heavy application of nitrogen in tea [Camellia sinensis] plants

Japanese journal of crop science, 1996-01, Vol.65 (1)

1996

Volltextzugriff (PDF)

Validation of a suitability map for soybean [Glycine max] in the drained paddy field based on the geographical information system for agricultural production

Japanese Journal of Soil Science and Plant Nutrition, 1994/06/05, Vol.65(3), pp.282-289

1994

Volltextzugriff (PDF)

Behavior of inorganic nitrogen in tea [Camellia sinensis] field soils heavily applied with nitrogen and changes in amino acid content of the first crop accompanying the reduction of nitrogen

Japanese journal of crop science, 1995-09, Vol.64 (3)

1995

Volltextzugriff (PDF)

Measurement of root surface area of spinach [Spinacia oleracea] by image processing

Japanese Journal of Soil Science and Plant Nutrition, 1991/08/05, Vol.62(4), pp.410-416

Yasuda, N. (Mie-ken. Agricultural Technical Center, Ureshino (Japan))

1991

Volltextzugriff (PDF)

Improvement of manufacturing process for Kamairicha and development of a experimental tea manufacturing machine

Chagyo Kenkyu Hokoku (Tea Research Journal), 1998/03/31, Vol.1998(86), pp.43-50

Tanaka, N. (Saga-ken. Tea Experiment Station, Ureshino (Japan))

1998

Volltextzugriff (PDF)

Development of a experimental tea [Camellia sinensis] producing machine using new-ceramics, 1: Utilization of new-ceramics for a tea leaf parcher

Chagyō kenkyū hōkoku, 1997-02 (84)

1997

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(38)
Tagungsberichte
(1)

Sprache

Englisch
(28)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase II study of cetuximab rechallenge in patients with ras wild-type metastatic colorectal cancer: E-rechallenge trial

A multicenter retrospective study of gemcitabine plus nab-paclitaxel or FOLFIRINOX in metastatic pancreatic cancer: NAPOLEON study

Initial report of a phase I/II study of S-1 and irinotecan (IRIS) in combination with cetuximab in patients with wild-type RAS metastatic colorectal cancer

192P A multicenter crossover analysis of first and second-line FOLFIRINOX or gemcitabine plus nab-paclitaxel administered to pancreatic cancer patients: Results from the NAPOLEON study

SO-1 Prognostic nomogram to predict overall survival in patients with unresectable pancreatic cancer treated with gemcitabine plus nab-paclitaxel or FOLFIRINOX: Real-world results from the multicenter retrospective study (NAPOLEON study)

PD-5 Impact of biliary drainage for unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel: Results from the NAPOLEON study

P-88 A multicenter analysis of the correlation between overall survival and progression-free survival and the number of chemotherapeutic key drugs used in patients with advanced/unresectable pancreatic cancer: Results from the NAPOLEON study

Oxaliplatin-Induced Hypersensitivity Reactions in Patients with Advanced Colorectal Cancer in a Single Hospital

Development of a novel, fully-automated genotyping system: principle and applications

Prognostic impact of the C-reactive protein/albumin ratio in advanced pancreatic cancer treated with GEM plus nab-PTX or FOLFIRINOX: Based on the results of a multicenter retrospective study (the NAPOLEON study)

P-065A multicenter retrospective study of gemcitabine plus nab-paclitaxel or FOLFIRINOX in metastatic pancreatic cancer: NAPOLEON study

481PPhase II study of cetuximab rechallenge in patients with ras wild-type metastatic colorectal cancer: E-rechallenge trial

493PInitial report of a phase I/II study of S-1 and irinotecan (IRIS) in combination with cetuximab in patients with wild-type RAS metastatic colorectal cancer

Gemcitabine Plus Radiotherapy in Patients with Unresectable Locally Advanced Pancreatic Cancer

A noninvasive system for monitoring resistance to EGFR tyrosine kinase inhibitors with plasma DNA

Rectal MALT lymphoma regression and anti-Helicobacter pylori therapy

P1301: BIOLOGICAL SIGNIFICANCE OF UCK2 IN HTLV‐1‐INFECTED CELLS IN ATL LEUKEMOGENESIS AND ACQUIRED RESISTANCE TO AZACITIDINE

P413: THE POTENTIAL USE OF AN ORAL HYPOMETHYLATING AGENT, OR‐2100, AS A COMBINATION THERAPY FOR MYELOID MALIGNANCIES

ACE2 OVEREXPRESSION CHANGES THE SARS-COV-2 INFECTION PROFILE IN BEAS-2B CELLS

Changes in nitrogen uptake with aging and under heavy application of nitrogen in tea [Camellia sinensis] plants

Validation of a suitability map for soybean [Glycine max] in the drained paddy field based on the geographical information system for agricultural production

Behavior of inorganic nitrogen in tea [Camellia sinensis] field soils heavily applied with nitrogen and changes in amino acid content of the first crop accompanying the reduction of nitrogen

Measurement of root surface area of spinach [Spinacia oleracea] by image processing

Improvement of manufacturing process for Kamairicha and development of a experimental tea manufacturing machine

Development of a experimental tea [Camellia sinensis] producing machine using new-ceramics, 1: Utilization of new-ceramics for a tea leaf parcher

Suchergebnisse filtern